Home » Topics » Regulatory

Regulatory
RSS

Antidepressant efficacy demonstrated with amantadine

Sep. 23, 1998

Wealth of clinical data support efficacy of ziprasidone

Sep. 23, 1998

FDA will give priority review to Nabi's reformulated H-BIG

Sep. 23, 1998

Another SSRI success story: sertraline safe and effective in patients with panic disorder

Sep. 23, 1998

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Another treatment option added to the anti-HIV arsenal: efavirenz gets FDA approval

Sep. 21, 1998

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Early 1999 launch dates anticipated for EchoGen in European markets

Sep. 18, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...